Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia.
Dominique Frances LeitnerEvgeny KanshinManor AskenaziYik SiuDaniel FriedmanSasha DevoreDrew R JonesBeatrix UeberheideThomas WisniewskiOrrin DevinskyPublished in: PloS one (2022)
ClinicalTrials.gov NCT02451696.
Keyphrases